The creatine kinase-isoenzyme MB (CK-MB) mass assay is one of the laboratory tests used for the diagnosis of myocardial infarction. It is recommended, however, that reference limits should take gender ...
Nearly 7 million patients present to U.S. emergency departments annually for evaluation of possible acute coronary syndromes (ACSs). Despite hospital admission of the 25% to 30% who have atypical ...
1 School of Basic Medical Sciences, Youjiang Medical University for Nationalities, Baise, China. 2 Guangxi Database Construction and Application Engineering Research Center for Intracorporal ...
1 Department of Internal Medicine, Enshu General Hospital, Hamamatsu, Japan 2 Department of Internal Medicine, Johoku Hospital, Nagoya, Japan 3 Internal Medicine and Molecular Science, Graduate School ...
According to Nova One Advisor, the global heart attack diagnostics market size was exhibited at USD 11.18 billion in 2023 and is projected to hit around USD 25.05 billion by 2033, growing at a CAGR of ...
The fight against heart disease receives a vital boost with the growing Cardiac Biomarker Diagnostic Test Kits Market. A recent industry analysis reveals the market is poised for significant growth, ...
The Cardiac Biomarker Diagnostic Test Kits Market is poised for steady growth, fueled by the increasing burden of cardiovascular diseases (CVDs). A recent industry analysis reveals a current market ...
Serum troponins and CK-MB (creatine kinase-MB) are readily detectable and reliable cardiac-specific biomarkers of subclinical myocardial injury. This study explores the roles of cTnI (cardiac troponin ...
Some patients with autism spectrum disorder (ASD) exhibit elevated serum creatine kinase levels, which are believed to be associated with mitochondrial dysfunction. Although a few articles have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results